Notice to Employees of AstraZeneca Pharmaceuticals LP

This document is about AstraZeneca Pharmaceuticals LP and its captive insurance company AZ-Mont applying to the U.S. Department of Labor for authorization of a reinsurance transaction. The transaction would reinsure the risks and premiums for AstraZeneca's long-term disability insurance plan, and includes benefit improvements such as a terminal illness benefit, rehabilitative incentive, family care expenses, moving expenses, and a work incentive. The document outlines the parties involved, the proposed changes, and the conditions of the DOL authorization.